![PDF) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio- Oncology Society (IC-OS) PDF) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio- Oncology Society (IC-OS)](https://i1.rgstatic.net/publication/362963968_2022_ESC_Guidelines_on_cardio-oncology_developed_in_collaboration_with_the_European_Hematology_Association_EHA_the_European_Society_for_Therapeutic_Radiology_and_Oncology_ESTRO_and_the_International_C/links/630c5d1361e4553b95479032/largepreview.png)
PDF) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio- Oncology Society (IC-OS)
![The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology](https://www.jacc.org/pb-assets/journals/cardio-oncology/most-read/2022/imgs/122921-0601DR%20Omland.jpg)
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
![Alfonso Valle on Twitter: "#Cardio-Oncology by @TeresaLpezFdez1 🧑💻272 new recommendations‼️ 🥇 ACE- or ARB and beta-blockers recomended for HF should be considered for primary preventjon in high- and very high-risk 👥 receiving Alfonso Valle on Twitter: "#Cardio-Oncology by @TeresaLpezFdez1 🧑💻272 new recommendations‼️ 🥇 ACE- or ARB and beta-blockers recomended for HF should be considered for primary preventjon in high- and very high-risk 👥 receiving](https://pbs.twimg.com/media/FbEbBg0WAAAEMsC.jpg:large)
Alfonso Valle on Twitter: "#Cardio-Oncology by @TeresaLpezFdez1 🧑💻272 new recommendations‼️ 🥇 ACE- or ARB and beta-blockers recomended for HF should be considered for primary preventjon in high- and very high-risk 👥 receiving
![Revisión 2022 ESC Guidelines on cardiooncology developed in collaboration EHA, the ESTRO and ICOS - YouTube Revisión 2022 ESC Guidelines on cardiooncology developed in collaboration EHA, the ESTRO and ICOS - YouTube](https://i.ytimg.com/vi/F9kTVkh_mPo/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLDou75jqbnyRkgN7waP7245ntlVPg)
Revisión 2022 ESC Guidelines on cardiooncology developed in collaboration EHA, the ESTRO and ICOS - YouTube
![Research in progress blog Cardio-Oncology is now the official journal of the International Cardio-Oncology Society (ICOS) Research in progress blog Cardio-Oncology is now the official journal of the International Cardio-Oncology Society (ICOS)](https://blogs.biomedcentral.com/bmcblog/wp-content/uploads/sites/7/2018/09/ICOS-logo.jpg)
Research in progress blog Cardio-Oncology is now the official journal of the International Cardio-Oncology Society (ICOS)
![Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week - ScienceDirect Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719339300-fx1.jpg)